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SUMMARY 
 
A 6-year-old intact Persian cat was presented for the primary complaint of inappetence and weight loss. Irregular surface of 
kidneys was palpated during physical examination. Abdominal radiograph findings were indicative of renomegaly. Ultrasonography 
revealed multiple anaechoic structures within the renal parenchyma. The cortex, medulla and renal pelvis were unable to be 
differentiated. Both radiographic and ultrasonographic findings were suggestive of polycystic kidney disease. Blood test revealed 
normochromic, normocytic anaemia with azotaemia whereas urinalysis findings were hypostenuria and proteinuria, consistent of 
chronic kidney disease due to polycystic kidney. Ultrasound is a useful antemortem diagnostic tool to diagnose polycystic kidney 
disease in cats. 
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INTRODUCTION 
 
Polycystic kidney disease (PKD) is an inherited 
disorder characterised by more than one fluid-filled cysts 
found in the kidney (Eaton et al., 1997). Humans, cats 
especially Persians and Persian-related breeds, and dogs 
were reported to be affected with PKD (Chalifoux et al., 
1982; Biller et al., 1996; Eaton et al., 1997; Igarashi et al., 
2002). These cysts tend to multiply in numbers and grow 
in size over time, causing progressive deterioration of 
kidney tissue and often leads to potentially fatal kidney 
failure (Wills et al., 2005). To date, development of these 
cysts in the kidney has been associated to genetic anomaly 
that is evident primarily in Persian cats. Autosomal 
dominant polycystic kidney disease (ADPKD) has been 
identified as an inherited form in Persian cats (Cooper et 
al., 2000). This article focuses on the importance of 
diagnostic work up mainly, ultrasonography, for the 
diagnosis of polycystic kidney disease and the treatment 
regime. 
 
CASE REPORT 
 
A 6-year-old intact male Persian cat was presented to 
University Veterinary Hospital, Universiti Putra Malaysia 
(UVH-UPM) for the primary complaint of inappetence 
and weight loss. Cat was previously diagnosed with 
urolithiasis and kidney disease about two years ago. The 
definitive diagnosis of kidney disease was not 
investigated.  
Physical examination revealed normal temperature 
and normal pulse rate but the cat had an increased 
respiratory rate of 48 breaths per minutes (tachypneic).  
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The cat was 7% dehydrated with pale mucous 
membrane and the capillary refill time was less than 2 
seconds. Halitosis was noted. Upon palpation of the 
abdomen, the cat has a small flaccid and compressible 
urinary bladder of about 2 cm in size and diluted urine 
was collected upon manual bladder compression. The 
kidneys were bilateral enlarged with irregular surfaces but 
were not painful upon palpation. Polydipsia and polyuria 
were observed during hospitalisation. The differential 
diagnoses at this point of time were polycystic kidney 
disease, neoplasia such as lymphoma, pseudonephritic 
cyst, renal hematoma, and renal abscess. Diagnostic work-
up carried out were complete blood count and serum 
biochemistry, urinalysis, abdominal radiography and 
ultrasonography.   
Complete blood count (Table 1) on day-1 revealed 
low normal packed cell volume (PCV) with elevated 
plasma protein which was consistent with the physical 
examination findings of dehydration. Serum biochemistry 
findings (Table 2) were hypochloremia, 
hyperphosphataemia, azotaemia (elevated blood urea 
nitrogen and creatinine concentrations) and elevated 
globulin concentrations. After five days of fluid therapy to 
correct the dehydration and for the purposes of diuresis, 
the chloride and inorganic phosphate level were back to 
normal but the cat were hypokalaemic and hypocalcaemic. 
The urea and blood urea nitrogen level were persistently 
high despite of slight reduction compared to day-1. 
Urinalysis on day-1 revealed urine with specific 
gravity of 1.010 despite the dehydration. Findings 
indicated that the kidneys were unable to concentrate 
urine probably due to impaired renal tubular function. 
Urine protein and creatinine ratio of 4.8 (<0.5) revealed 
evidence of proteinuria, suggestive of protein-losing 
nephropathy and glomerular disease such as 
glomerulonephritis and glomerular basement membrane 
damage (Villiers and Blackwood, 2005).  
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Table 1. Complete blood count results on Day-1 (prior 
to treatment) and Day-5 post hospitalisation. 
 
Complete blood 
count 
Day-1 Day-5 Normal 
range 
PCV (L/L) 0.27 0.18 0.24-0.45 
Plasma protein 
(g/L) 
98.0 75.0 60.0-80.0 
Reticulocytes 
(/100RBC) 
0.1 - 0.5-1.5 
Erythrocytes 
(x1012/L) 
5.6 - 5.0-10.0 
Haemoglobin (g/L) 95.9 - 80.0-150.0 
MCV (fL) 48.0 - 39.0-55.0 
MCHC (g/L) 355.0 - 300.0-360.0 
WBC (x 109/L) 11.9 - 5.5-19.5 
Day-1, first day of admission prior to treatment; Day-5, day-5 post 
hospitalisation; PCV, packed cell volume; RBC, red blood cells; MCV, 
mean corpuscular volume; MCHC, mean corpuscular haemoglobin 
concentration; WBC, white blood cells; L/L, litre per litre; g/L, gram per 
litre;  fL, femtolitre. 
 
Table2. Serum biochemistry on Day-1 (prior to 
treatment) and Day-5 post hospitalisation. 
 
Serum biochemistry Day-1 Day-5 Normal 
range 
Sodium(mmol/L) 148.9 151.2 146.0-156.0 
Potassium 
(mmol/L) 
3.9 3.5 3.9-5.5 
Chloride (mmol/L) 105.1 112.2 110.0-132.0 
Calcium (mmol/L) - 1.8 2.2-2.9 
Inorganic 
Phosphate 
(mmol/L) 
3.9 2.6 1.1-2.8 
Urea (mmol/L) 72.9 44.5 3.0-10.0
Creatinine (µmol/L) 749.0 522.0 60.0-193.0 
Total Protein 
(Serum) (g/L) 
77.2 - 55.0-75.0 
Albumin (g/L) 31.0 - 25.0-40.0 
Globulin (g/L) 46.2 - 25.0-45.0 
A:G ratio 0.7 - 0.5-1.4
Day-1, first day of admission prior to treatment; Day-5, day-5post 
hospitalisation; mmol/L, millimol per litre; µmol/L, micromol per litre; 
g/L, gram per litre. 
 
Radiographic findings (Figure 1) showed bilaterally 
enlarged kidneys with the measured width three times the 
width of the second lumbar vertebrae indicating 
renomegaly. Ultrasonographic findings (Figure 2) 
revealed mutiple anaechoic structures within the renal 
parenchyma suggestive of cysts and poorly differentiated 
structure of the cortex, medulla, and renal pelvis. 
Approximately, there were 19 and 18 cysts of various 
sizes in the left and right kidney, respectively of various 
sizes. Approximately 50% of the renal parenchyma was 
estimated to be affected in both kidneys. Combination 
findings from all the diagnostic work-outs concluded that 
the cat had chronic kidney disease Stage IV (IRIS, 2013) 
due to polycystic kidney disease. 
The cat was managed as a chronic kidney disease 
Stage IV patient throughout hospitalisation. As  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  (Top and 
left) Abdominal 
radiograph 
revealed bilateral 
enlarged kidney 
suggestive of 
renomegaly. 
 
 
Figure 2. Ultrasonography images of left and right 
kidneys revealed multiple anechoic cysts in renal 
parenchyma. 
 
hypokalaemia was present on day-5 of hospitalisation, 
potassium chloride was supplemented to the fluid therapy. 
Ipakitine (Vetoquinol, United Kingdom) at the dosage of 
1 g/ 5 kg PO BID was added in food which acted as a 
phosphate binder for hyperphosphatemia. Ornipural 
(Vetoquinol, United Kingdom), a liver protectant was 
administered  at the dosage of 1 ml/cat IV BID to prevent 
hepatic lipidosis, and vitamin B complex (Pharmaniaga, 
Malaysia) as an appetite stimulant was administered as the 
cat was inappetent. Additionally, a/d® Canine/Feline 
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Critical Care (Hill’s® Prescription Diet®, Hill’s Pets 
Nutrition, United States) was fed to maintain adequate 
calories intake of the cat. The prognosis of the cat was 
poor to guarded. On day-6 of hospitalisation, the owner 
opted to stop treatment and the cat was discharged. 
 
DISCUSSION 
 
PKD is a genetic disease that affects the kidney. It is 
a genetic disease which leads to the development of 
multiple cysts in the kidneys. PKD in Persians was 
identified as an autosomal dominant polycystic kidney 
disease (ADPKD). According to the Mendelian 
inheritance, autosomal dominant is one of several ways a 
trait or disorder can be passed down through families, 
where dominant conditions are expressed in individuals 
who have just one copy of the mutant allele (Genetic 
Alliance, 2010). Hence, in an autosomal dominant 
disease, the cat can inherit the abnormal gene from only 
one parent. Approximately 37% of Persian cats are 
affected with PKD according to the Cat Fanciers’ 
Association registration published in 2004. 
Lyons (2004) discovered a stop mutation at gene 
PKD1 in cats diagnosed with PKD. In human, most 
ADPKD arise from mutations in PKD1, encoding 
polycystin-1 (PC1), leading to deregulated renal cell 
growth, loss of epithelial cell polarity and fibrosis. 
Development of ADPKD is associated with the elevated 
activity of numerous signalling proteins that control 
proliferation and cell-environment interactions. This leads 
to erroneous tubulogenesis in the kidney. At the early 
stage, microcysts are hard to be noticed with naked eyes. 
As the patient ages, more and/or bigger cysts will be 
formed causing the kidney function to be compromised 
and eventually leads to renal failure and chronic kidney 
disease (Lyons et al., 2004). 
PKD cats diagnosed with kidney disease are 
commonly presented with the combination of clinical 
signs such as polyuria, polydipsia, inappetence, weight 
loss, nausea, vomiting, and lethargy (Eaton et al., 1997). 
However, not all PKD cats have clinical signs suggestive 
of kidney disease. They can appear as normal healthy cats 
without azotaemia and often, renal cysts are an incidental 
findings during routine abdominal ultrasound for health 
screening (Wills et al., 2009).  
There is no gold standard test for the ante mortem 
diagnose of PKD. A confirmatory diagnosis can be made 
at post mortem (Wills et al., 2009). Therefore, 
ultrasonography is a practical way to diagnose PKD as it 
is the safe, readily available, and least invasive when 
compared to other diagnostic tests such as computed 
tomography and magnetic resonance imaging (Eaton et 
al., 1997; Denez et al., 2008). The sensitivity of 
ultrasound scanning in the detection of PKD is up to 91% 
(Eaton et al., 1997).  
Recently genetic testings for PKD1 gene has been 
developed to identify ADPKD in Persians and Persian-
related breeds. Genetic testing is useful for confirmation 
of the gene mutation but unfortunately, it is not available 
in Malaysia. This genetic test cannot predict the severity 
of disease, therefore, does not allow monitoring of disease 
progression in affected cats (Wills et al., 2009). Clinicians 
often depend on ultrasonography and blood profiles to 
monitor disease progression for each individual cat. 
Another setback of the genetic test is that a cat can be 
diagnosed with PKD but it is not associated with this 
ADPKD gene that is detected by the mentioned test as 
ADPKD is not the only possible cause of a cyst in a cat’s 
kidney. Other genetic forms of PKD are seen in humans 
where they make up around 15% of cases (Torres and 
Harris, 2006). AD-PKD1 is the only form recognised in 
cats but there are suspicions that other forms occur; albeit 
much less commonly (Kappe et al 2005, Helps et al., 
2007, Bonazzi et al., 2009, Lee et al., 2010). Kidney cysts 
can also occasionally form in cats secondary to other 
causes of chronic kidney disease; these are most likely in 
older cats (Norsworthy, 2003). 
Ultrasound guided drainage of the cyst has been 
reported as treatment for cats diagnosed with PKD 
(Norsworthy et al., 2003). This procedure is usually 
carried out if the patient have severe painful kidney due to 
the severely enlarged renal cyst (Norsworthy et al., 2003). 
Often PKD cats develop chronic kidney disease and are 
managed with the combination of diet control, fluid, and 
supportive therapy. Latest studies of signaling pathways 
in primary cilium of the epithelial cells composing the 
renal tubules that are perturbed in PKD have identified 
potential targets for pharmacological therapy (Patel et al., 
2009). Drugs that have shown efficacy in preclinical 
studies utilising orthologous animal models of PKD 
include tolvaptan, octreotide, src inhibitors, CFTR 
inhibitors, pioglitazone, etanercept, and triptolide. These 
drugs are currently being evaluated in humans (Patel, 
2009) and have not been approved for clinical trial in cats. 
 
CONCLUSION 
 
PKD in Persian cats is a genetic disorder.  As the 
renal cysts grow, the cat may develop chronic kidney 
disease. Screening before breeding is highly 
recommended.  Any cat considered to be a possible carrier 
of the gene responsible for the disorder, especially a 
Persian cat must undergo a test to determine whether or 
not it is indeed harbouring the responsible gene. If it turns 
out that the cat is in fact carrying the gene, it must not be 
allowed to breed. However, this test is not available in 
Malaysia. The only practical way of prevention and 
control of the disease is screening via ultrasonography and 
cats diagnosed with PKD should not be bred. 
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